WuXi AppTec earns tenth CRDMO award while WuXi AppTec stock costs EUR 20.88

Published on 10/22/2026 at 09:26 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

WuXi AppTec wins a tenth CRDMO award on October 19, 2026. WuXi AppTec stock costs EUR 20.88 on October 22, 2026, with H1 revenue at RMB 28.90 billion.

Recognition and operating figures

WuXi AppTec received its tenth consecutive CRDMO recognition on October 19, 2026.
First-half 2026 revenue reached RMB 28.90 billion, up 38.93 percent year over year.
WuXi AppTec stock trades at EUR 20.88 at 9:17 a.m. CEST at Lang & Schwarz on October 22, 2026.

WuXi AppTec, CNE100003F19, Illustration mit AI erstellt.

WuXi AppTec (CNE100003F19) stock costs EUR 20.88 at Lang & Schwarz on October 22, 2026, while the company has secured a tenth consecutive CRDMO industry recognition. The award gives investors a fresh operating signal as the company prepares to report its third-quarter results.

Tenth recognition on October 19

WuXi AppTec said on October 19, 2026, that Frost & Sullivan had named it the 2026 Global Company of the Year in the CRDMO industry. The recognition marked the tenth consecutive year in which WuXi AppTec received the award.

The company operates an integrated contract research, development and manufacturing platform for pharmaceutical and life sciences customers. Its services cover research, development and manufacturing across Asia, Europe and North America, according to its investor-relations overview.

H1 growth sets the operating context

Revenue for the first half of 2026 reached RMB 28.90 billion, an increase of 38.93 percent from the year-earlier period, according to BioSynergy Pharm. The small-molecule business generated RMB 14.99 billion in the same period, up 72.70 percent year over year.

WuXi AppTec raised its 2026 total revenue guidance to RMB 58.5 billion to RMB 60.5 billion from RMB 51.3 billion to RMB 53.0 billion, as reported by Simply Wall St. The higher range makes execution and customer demand the central operating questions for the next report.

What comes next for results

Simply Wall St lists October 27, 2026, as the date for WuXi AppTec to report third-quarter results. That release should provide the next dated test of the raised full-year revenue range and the conversion of first-half growth into the second half.

Euro quote and investor context

For investors, the recognition is supportive context, but the larger measurable signal is the 38.93 percent first-half revenue increase and the higher 2026 guidance range. The current German-market indication places the stock alongside that operating evidence rather than replacing it.

WuXi AppTec was trading at EUR 20.88 at Lang & Schwarz on October 22, 2026 at 9:17 a.m. CEST. The further course of trading is shown by the continuously updated real-time quote of WuXi AppTec stock.